Social commerce firm Alphaeon has completed the acquisition of US-based commercial stage medical device firm, Lensar.
Terms of the deal have not been disclosed. However, the transaction is valued at up to $59m, said Alphaeon while first signed agreement in November this year.
Established in 2004, Lensar produces Femtosecond lasers systems (FLS) through its wholly owned subsidiary.
The company developed the femtosecond cataract laser to enable automation of several critical surgical procedure planning and delivering elements.
The Lensar laser system provides patients with better outcome following the removal of their crystalline lens.
Alphaeon CEO Robert Grant said: "We are pleased to have closed the acquisition of Lensar.
"The advancements they have made in the self-pay category of precision refractive surgery complement our lifestyle product portfolio, allowing ophthalmologists to offer another alternative to patients."
The deal allows Alphaeon to expand its ophthalmology business, offering advanced technology to its network of around 4,200 board-certified ophthalmologists across the globe.
In December 2014, Alphaeon also acquired Canada-based Clarion Medical Technologies, for around $55m.
Established in 1989, Clarion supplies medical and aesthetic equipment and consumables for hospitals and private practices in Canada.
Image: Alphaeon has acquired commercial stage medical device firm Lensar. Photo: courtesy of adamr / FreeDigitalPhotos.net.